Johnson & Johnson Inc in Consumer Health (World)

Johnson & Johnson Inc in Consumer Health (World)

  • October 2020 •
  • 35 pages •
  • Report ID: 5983023 •
  • Format: PDF
In light of Coronavirus, Johnson & Johnson is expected to perform above industry average in 2020, boosted by the successes of its analgesics and cough, cold and allergy remedies brands. While its OTC portfolio is well positioned to see growth at the global level, J&J would be wise to diversify its sales in high-growth economies and expand its vitamins and dietary supplements offerings.

Johnson & Johnson Inc in Consumer Health (World) Company Profile offers detailed strategic analysis of the company’s business, examining its performance in the Consumer Health industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.

Product coverage:
Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.